You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Obtenez les dernières mises à jour ou faites une autoévaluation.

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils
À propos des lignes directrices

Systemic Therapy for Advanced or Recurrent Endometrial Cancer and Advanced or Recurrent Uterine Papillary Serous Carcinoma

Version: 4 ID: 4-8 jul 2019
Type of Content: Guidelines & Advice, Clinical
Document Status: In-Review
Authors:
Members of the Gynecology Cancer Disease Site Group, Gynecology Cancer Disease Site Group

Patient Population

Adult patients diagnosed with advanced stage or recurrent endometrial cancer (excluding sarcomas and squamous cell carcinomas) or uterine papillary serous carcinoma.

Research Question(s)

  1. What are the chemotherapeutic and hormonal therapy options for women with advanced or recurrent endometrial cancer (excluding sarcomas and squamous cell carcinomas)?
  2. What are the chemotherapeutic options for women with advanced or recurrent uterine papillary serous carcinoma?
pdf download Summary (PDF) (283.15 Ko)
pdf download Full Report (PDF) (1.83 Mo)